Şunu aradınız:: paternal (İngilizce - Maltaca)

there have also been reports of congenital abnormalities and spontaneous abortion following either maternal or paternal exposure.
kien hemm ukoll rapporti ta’ abnormalitajiet konġenitali u abort spontanju wara l-espożizzjoni jew tal-omm jew tal-missier.

their paternal, master-student relationship gradually becomes a complex and ambiguous one of dependence and manipulation.
ir-relazzjoni paterna tagħhom ta' mgħallem u student bil-mod il-mod issir waħda kumplessa u ambigwa ta' dipendenza u manipulazzjoni.

for example, paternal filiation established in one member state with respect to a child born there will not necessarily be recognised in another member state because of the difference in national rules applicable to the matter.
pereżempju, relazzjoni paterna stabbilita fi stat membru fir-rigward ta’ tifel/tifla li twieled fih ma tkunx neċessarjament rikonoxxuta fi stat membru ieħor minħabba d-diverġenza fir-regoli nazzjonali applikabbli għal din il-kwistjoni.

although data on approximately 300 prospectively followed pregnancies with paternal exposure to ribavirin have not shown an increased risk of malformation compared to the general population, nor any specific pattern of malformation, either male patients or their female partners of childbearing age must be advised to use an effective contraceptive during treatment with ribavirin and for seven months after treatment.
għalkemm tagħrif minn madwar 300 tqala b’missirijiet li ġew esposti għal ribavirin li ġew segwiti b’mod prospettiv, ma wrewx żieda fir-riskji ta’ malformazzjonijiet meta mqabbla mal-popolazzjoni ġenerali, u lanqas xi skema speċifika ta’ malformazzjoni, il-pazjenti rġiel jew is-sieħba nisa tagħhom li jista’ jkollhom it- tfal għandhom jingħataw parir sabiex it-tnejn jużaw kontraċettivi effettivi waqt it-trattament b’ribavirin u għal seba’ xhur wara t-trattament.

although data on approximately 300 prospectively followed pregnancies with paternal exposure to ribavirin have not shown an increased risk of malformation compared to the general population, nor any specific pattern of malformation, male patients and their female partners of childbearing age must be counseled to each use an effective contraceptive during treatment with rebetol and for seven months after treatment men whose partners are pregnant must be instructed to use a condom to minimise delivery of ribavirin to the partner.
għalkemm tagħrif minn madwar 300 tqala b’ missirijiet li ġew esposti għal ribavirin li kienu segwiti b’ mod